Twist Bioscience (TWST) Total Liabilities (2018 - 2026)

Twist Bioscience (TWST) has reported Total Liabilities for 9 consecutive years, with $221.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Liabilities rose 42.19% year-over-year to $221.1 million; the TTM figure through Mar 2026 stood at $221.1 million (up 42.19% YoY), while the FY2025 annual figure was $168.9 million, up 19.25% from the prior year.
• Total Liabilities rose to $221.1 million in Q1 2026 per TWST's latest filing, from $182.0 million in the prior quarter.
• Across five years, Total Liabilities topped out at $221.1 million in Q1 2026 and bottomed at $141.6 million in Q3 2024.
• Historically, Total Liabilities has averaged $160.5 million across 5 years, with a median of $155.5 million in 2025.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 2627.42% — and 2023, when it fell 12.75%.
• Twist Bioscience's Total Liabilities stood at $163.6 million in 2022, then dropped by 12.75% to $142.8 million in 2023, then increased by 6.91% to $152.6 million in 2024, then climbed by 19.23% to $182.0 million in 2025, then grew by 21.5% to $221.1 million in 2026.
• Business Quant data shows TWST's Total Liabilities at $221.1 million in Q1 2026, $182.0 million in Q4 2025, and $168.9 million in Q3 2025.